V-Wave

About:

V-Wave is a medical device company that develops percutaneous implantable devices for patients with chronic heart failure.

Website: http://vwavemedical.com

Twitter/X: vwavemedical

Top Investors: Deerfield, Johnson & Johnson Innovation – JJDC, Triventures, Aperture Venture Partners, BRM Capital

Description:

V-Wave is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity, and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing, and bringing to market multiple implantable cardiovascular devices.

Total Funding Amount:

$226M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2010-01-01

Contact Email:

info(AT)vwavemedical.com

Founders:

Yaacov Nitzan

Number of Employees:

51-100

Last Funding Date:

2021-12-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai